Sotera Health’s sale of medical isotopes business to BWX complete

Sotera Health LLC closed the sale of its medical Isotopes segment within its Nordion business to BWX Technologies Inc. With the sale, BWXT now owns Nordion's former medical isotopes business, including the radiochemical and contract manufacturing operations in Kanata, Ontario, and the isotope production facility in Vancouver, British Columbia, along with the transfer of approximately 150 employees. Nordion retains ownership of its gamma technologies business as well as its state-of-the-art licensed facility in Kanata. Separately, the companies also signed a long-term lease agreement that will allow BWXT to continue operating from Nordion's Kanata facility. “We are seeing significant growth and new business opportunities for gamma technologies, especially in the exciting new therapeutic applications that are emerging for medical cobalt-60,” Sotera CEO Michael B. Petras Jr. said in a statement. “This sale allows Nordion to focus its full attention on accelerating growth in gamma technologies to bring our customers additional value in support of our Sotera Health mission.”